151 related articles for article (PubMed ID: 38672555)
1. CD10 Expression Correlates with Earlier Tumour Stages and Left-Sided Tumour Location in Colorectal Cancer but Has No Prognostic Impact in a European Cohort.
Grass JK; Grupp K; Kluth M; Hube-Magg C; Simon R; Kemper M; Izbicki JR; Sauter G; Melling N
Cancers (Basel); 2024 Apr; 16(8):. PubMed ID: 38672555
[TBL] [Abstract][Full Text] [Related]
2. [Expression of CD10 in cancer-associated fibroblasts and its effect on initiation and progression of colorectal carcinoma].
Zhu Y; Zheng JJ; Yang F; Nie QQ; Zhu ZL; Deng H
Zhonghua Bing Li Xue Za Zhi; 2016 Dec; 45(12):859-865. PubMed ID: 28056302
[No Abstract] [Full Text] [Related]
3. Does CD10 Expression Predict Lymph Node Metastasis in Colorectal Cancer?
Bernescu I; Reichstein AC; Luchtefeld M; Ogilvie JW
Dis Colon Rectum; 2016 Jan; 59(1):22-27. PubMed ID: 26651108
[TBL] [Abstract][Full Text] [Related]
4. CD10 inhibits cell motility but expression is associated with advanced stage disease in colorectal cancer.
Raposo TP; Comes MS; Idowu A; Agit B; Hassall J; Fadhil W; Nica R; Ecker R; Yao T; Ilyas M
Exp Mol Pathol; 2018 Jun; 104(3):190-198. PubMed ID: 29653092
[TBL] [Abstract][Full Text] [Related]
5. [Analysis of clinicopathological features and prognosis of sporadic synchronous multiple primary colorectal cancers].
Qin ZF; Xu GH; Zhou SQ; Zheng PW; Zhu YP; Ju HX; Li DC; Ma DN
Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Dec; 26(12):1171-1178. PubMed ID: 38110279
[No Abstract] [Full Text] [Related]
6. Colorectal cancer liver metastases - a population-based study on incidence, management and survival.
Engstrand J; Nilsson H; Strömberg C; Jonas E; Freedman J
BMC Cancer; 2018 Jan; 18(1):78. PubMed ID: 29334918
[TBL] [Abstract][Full Text] [Related]
7. Impact of sidedness of colorectal cancer on tumor immunity.
Takasu C; Nishi M; Yoshikawa K; Tokunaga T; Kashihara H; Yoshimoto T; Shimada M
PLoS One; 2020; 15(10):e0240408. PubMed ID: 33045001
[TBL] [Abstract][Full Text] [Related]
8. [Expression of CD10 in tumor-associated fibroblast of cancerized or recurrent colorectal adenomas].
Zheng J; Zhu Y; Li C; Li Y; Nie Q; Zhu Z; Deng H
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2016 May; 45(4):335-341. PubMed ID: 27868405
[TBL] [Abstract][Full Text] [Related]
9. The impact of primary tumour location in patients undergoing hepatic resection for colorectal liver metastasis.
Wang K; Xu D; Yan XL; Poston G; Xing BC
Eur J Surg Oncol; 2018 Jun; 44(6):771-777. PubMed ID: 29580735
[TBL] [Abstract][Full Text] [Related]
10. Primary tumour location affects survival after resection of colorectal liver metastases: A two-institutional cohort study with international validation, systematic meta-analysis and a clinical risk score.
Gasser E; Braunwarth E; Riedmann M; Cardini B; Fadinger N; Presl J; Klieser E; Ellmerer P; Dupré A; Imai K; Malik H; Baba H; Ulmer H; Schneeberger S; Öfner D; Dinnewitzer A; Stättner S; Primavesi F
PLoS One; 2019; 14(5):e0217411. PubMed ID: 31150437
[TBL] [Abstract][Full Text] [Related]
11. High CD10 expression in lymph node metastases from surgically treated prostate cancer independently predicts early death.
Fleischmann A; Rocha C; Saxer-Sekulic N; Zlobec I; Sauter G; Thalmann GN
Virchows Arch; 2011 Jun; 458(6):741-8. PubMed ID: 21538124
[TBL] [Abstract][Full Text] [Related]
12. Prognostic impact of primary tumour location after curative resection in Stage I-III colorectal cancer: a single-centre retrospective study.
Inoue M; Kanemitsu Y; Tsukamoto S; Moritani K; Takamizawa Y; Daiko H
Jpn J Clin Oncol; 2024 Mar; ():. PubMed ID: 38535894
[TBL] [Abstract][Full Text] [Related]
13. Lymph node yield and tumour subsite are associated with survival in stage I-III colon cancer: results from a national cohort study.
Lykke J; Rosenberg J; Jess P; Roikjaer O;
World J Surg Oncol; 2019 Apr; 17(1):62. PubMed ID: 30940175
[TBL] [Abstract][Full Text] [Related]
14. The prognostic impact of primary tumour location in patients with stage II and stage III colon cancer receiving adjuvant therapy. A GISCAD analysis from three large randomised trials.
Cascinu S; Poli D; Zaniboni A; Lonardi S; Labianca R; Sobrero A; Rosati G; Di Bartolomeo M; Scartozzi M; Zagonel V; Pella N; Banzi M; Torri V
Eur J Cancer; 2019 Apr; 111():1-7. PubMed ID: 30797014
[TBL] [Abstract][Full Text] [Related]
15. HER3 expression in patients with primary colorectal cancer and corresponding lymph node metastases related to clinical outcome.
Lédel F; Hallström M; Ragnhammar P; Öhrling K; Edler D
Eur J Cancer; 2014 Feb; 50(3):656-62. PubMed ID: 24300455
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Implication of KRAS Status after Hepatectomy for Colorectal Liver Metastases Varies According to Primary Colorectal Tumor Location.
Sasaki K; Margonis GA; Wilson A; Kim Y; Buettner S; Andreatos N; Gani F; Amini N; Spolverato G; Pawlik TM
Ann Surg Oncol; 2016 Oct; 23(11):3736-3743. PubMed ID: 27352204
[TBL] [Abstract][Full Text] [Related]
17. Tumour budding - an additional prognostic factor in colorectal cancer survival.
Kamall GH; Ulusoy C; Nikolovski A; Kamall S
Pol J Pathol; 2023; 74(1):36-41. PubMed ID: 37306351
[TBL] [Abstract][Full Text] [Related]
18. Maspin is a marker for early recurrence in primary stage III and IV colorectal cancer.
Snoeren N; Emmink BL; Koerkamp MJ; van Hooff SR; Goos JA; van Houdt WJ; de Wit M; Prins AM; Piersma SR; Pham TV; Belt EJ; Bril H; Stockmann HB; Meijer GA; van Hillegersberg R; Holstege FC; Jimenez CR; Fijneman RJ; Kranenburg OW; Rinkes IH
Br J Cancer; 2013 Sep; 109(6):1636-47. PubMed ID: 24002600
[TBL] [Abstract][Full Text] [Related]
19. Keratin 7 expression in lymph node metastases but not in the primary tumour correlates with distant metastases and poor prognosis in colon carcinoma.
Czapiewski P; Bobowicz M; Pęksa R; Skrzypski M; Gorczyński A; Szczepańska-Michalska K; Korwat A; Jankowski M; Zegarski W; Szulgo-Paczkowska A; Polec T; Piątek M; Skokowski J; Haybaeck J; Żaczek A; Biernat W
Pol J Pathol; 2016; 67(3):228-234. PubMed ID: 28155971
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemistry-Based Consensus Molecular Subtypes as a Prognostic and Predictive Biomarker for Adjuvant Chemotherapy in Patients with Stage II Colorectal Cancer.
Li Y; Yao Q; Zhang L; Mo S; Cai S; Huang D; Peng J
Oncologist; 2020 Dec; 25(12):e1968-e1979. PubMed ID: 32926498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
